102 related articles for article (PubMed ID: 18724493)
1. Roche Labs update insert for saquinavir.
AIDS Alert; 2008 Aug; 23(8):94. PubMed ID: 18724493
[No Abstract] [Full Text] [Related]
2. Garlic supplements found to lower saquinavir levels.
TreatmentUpdate; 2001; 12(12):17-8. PubMed ID: 11570085
[No Abstract] [Full Text] [Related]
3. Why the old saquinavir (Invirase) may be bad for your health.
Vazquez E
Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV agents. Saquinavir with fosamprenavir.
TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
[No Abstract] [Full Text] [Related]
5. Drug interactions. Coming soon--a new formulation of saquinavir (Invirase).
TreatmentUpdate; 2006; 18(3):9. PubMed ID: 17209243
[No Abstract] [Full Text] [Related]
6. Saquinavir, the pioneer antiretroviral protease inhibitor.
la Porte CJ
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. Starting therapy with saquinavir.
TreatmentUpdate; 2007 Jan; 19(1):8-9. PubMed ID: 17393566
[No Abstract] [Full Text] [Related]
8. FDA notifications. Revised atazanavir package insert.
AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
[No Abstract] [Full Text] [Related]
9. FDA notifications. Roche issues letter about saquinavir.
AIDS Alert; 2005 Jul; 20(7):84. PubMed ID: 16110565
[No Abstract] [Full Text] [Related]
10. Saquinavir and rifampicin for tuberculosis and AIDS: new considerations.
Torres TS; Rolla VC
Int J Tuberc Lung Dis; 2006 Nov; 10(11):1302; author reply 1302-3. PubMed ID: 17131794
[No Abstract] [Full Text] [Related]
11. [HIV protease inhibitors].
Silbermann B; Yousry C; Salmon-Céron D
Ann Med Interne (Paris); 2000 Jun; 151(4):268-77. PubMed ID: 10922954
[No Abstract] [Full Text] [Related]
12. NIH studies link between saquinavir and garlic pills.
AIDS Alert; 2002 Feb; 17(2):26. PubMed ID: 11862747
[No Abstract] [Full Text] [Related]
13. [Roche begins phase III study with a new AIDS medication].
Immun Infekt; 1994 Jun; 22(3):VI. PubMed ID: 7927465
[No Abstract] [Full Text] [Related]
14. Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
Santos AF; Abecasis AB; Vandamme AM; Camacho RJ; Soares MA
J Antimicrob Chemother; 2009 Mar; 63(3):593-9. PubMed ID: 19136678
[TBL] [Abstract][Full Text] [Related]
15. FDA notifications. Updates made to Reyataz package insert.
AIDS Alert; 2008 Oct; 23(10):116-7. PubMed ID: 18935687
[No Abstract] [Full Text] [Related]
16. Revised package insert for atazanavir.
Sax PE
AIDS Clin Care; 2008 Mar; 20(3):23. PubMed ID: 18399014
[No Abstract] [Full Text] [Related]
17. Garlic supplements and saquinavir.
Borek C
Clin Infect Dis; 2002 Aug; 35(3):343. PubMed ID: 12115105
[No Abstract] [Full Text] [Related]
18. The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
McLean K; VanDeVen NA; Sorenson DR; Daudi S; Liu JR
Gynecol Oncol; 2009 Mar; 112(3):623-30. PubMed ID: 19147209
[TBL] [Abstract][Full Text] [Related]
19. Can inhibition of proteasomes or NF-kappaB help control idiopathic nephrotic syndrome?
Wenderfer SE
Nephrol Dial Transplant; 2012 May; 27(5):1698-701. PubMed ID: 22547747
[No Abstract] [Full Text] [Related]
20. FDA notifications. Fosamprenavir label is updated.
AIDS Alert; 2008 Feb; 23(2):21-2. PubMed ID: 18578033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
